CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution

Laurent Brossay(La Jolla Institute for Immunology), Mariacristina Chioda(La Jolla Institute for Immunology), Nicolas Burdin(La Jolla Institute for Immunology), Yasuhiko Koezuka(La Jolla Institute for Immunology), Giulia Casorati(La Jolla Institute for Immunology), Paolo Dellabona(La Jolla Institute for Immunology), Mitchell Kronenberg(La Jolla Institute for Immunology)
The Journal of Experimental Medicine
October 19, 1998
Cited by 646Open Access
Full Text

Abstract

Natural killer (NK) T cells are a lymphocyte subset with a distinct surface phenotype, an invariant T cell receptor (TCR), and reactivity to CD1. Here we show that mouse NK T cells can recognize human CD1d as well as mouse CD1, and human NK T cells also recognize both CD1 homologues. The unprecedented degree of conservation of this T cell recognition system suggests that it is fundamentally important. Mouse or human CD1 molecules can present the glycolipid alpha-galactosylceramide (alpha-GalCer) to NK T cells from either species. Human T cells, preselected for invariant Valpha24 TCR expression, uniformly recognize alpha-GalCer presented by either human CD1d or mouse CD1. In addition, culture of human peripheral blood cells with alpha-GalCer led to the dramatic expansion of NK T cells with an invariant (Valpha24(+)) TCR and the release of large amounts of cytokines. Because invariant Valpha14(+) and Valpha24(+) NK T cells have been implicated both in the control of autoimmune disease and the response to tumors, our data suggest that alpha-GalCer could be a useful agent for modulating human immune responses by activation of the highly conserved NK T cell subset.


Related Papers

No related papers found

Powered by citation graph analysis